Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders
June 13, 2024 16:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual...
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
June 12, 2024 16:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote...
Precipio Provides Status Update on Current Business Matters
June 12, 2024 09:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) provides the following update to its shareholders on various...
Precipio Secures a short-term $500K Credit Facility
May 06, 2024 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces it has secured a short-term loan facility of $500K to deal with any...
Precipio Announces Year end 2023 Shareholder Update Call
March 25, 2024 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its year end 2023 corporate update call on April 1st, 2024 at...
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY
February 13, 2024 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that for the full year of 2023, its unaudited revenues have grown...
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
February 06, 2024 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into a distribution agreement with Cardinal Health for...
Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter
January 23, 2024 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that continued revenue growth generated cash levels that bring the...
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
January 17, 2024 10:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for the...
Precipio Announces Christina Valauri joins the Board of Directors
January 02, 2024 09:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is pleased to welcome Christina Valauri to its board of directors effective Jan...